Liu Zhenyi, Brunskill Eric, Boyle Scott, Chen Shuang, Turkoz Mustafa, Guo Yuxuan, Grant Rachel, Kopan Raphael
SAGE Labs, St Louis, MO 63146, USA Department of Developmental Biology, Washington University, St Louis, MO 63110, USA.
Division of Developmental Biology, Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Development. 2015 Mar 15;142(6):1193-202. doi: 10.1242/dev.119529. Epub 2015 Feb 27.
We have previously described the creation and analysis of a Notch1 activity-trap mouse line, Notch1 intramembrane proteolysis-Cre6MT or N1IP::Cre(LO), that marked cells experiencing relatively high levels of Notch1 activation. Here, we report and characterize a second line with improved sensitivity (N1IP::Cre(HI)) to mark cells experiencing lower levels of Notch1 activation. This improvement was achieved by increasing transcript stability and by restoring the native carboxy terminus of Cre, resulting in a five- to tenfold increase in Cre activity. The magnitude of this effect probably impacts Cre activity in strains with carboxy-terminal Ert2 fusion. These two trap lines and the related line N1IP::Cre(ERT2) form a complementary mapping tool kit to identify changes in Notch1 activation patterns in vivo as the consequence of genetic or pharmaceutical intervention, and illustrate the variation in Notch1 signal strength from one tissue to the next and across developmental time.
我们之前描述了一种Notch1活性捕获小鼠品系Notch1膜内蛋白水解-Cre6MT或N1IP::Cre(LO)的构建及分析,该品系可标记经历相对高水平Notch1激活的细胞。在此,我们报告并表征了另一个具有更高敏感性的品系(N1IP::Cre(HI)),用于标记经历较低水平Notch1激活的细胞。这种改进是通过提高转录本稳定性和恢复Cre的天然羧基末端实现的,从而使Cre活性提高了五到十倍。这种效应的大小可能会影响带有羧基末端Ert2融合的品系中的Cre活性。这两个捕获品系以及相关品系N1IP::Cre(ERT2)形成了一个互补的定位工具包,用于识别体内由于基因或药物干预导致的Notch1激活模式的变化,并说明了Notch1信号强度在不同组织之间以及整个发育过程中的差异。